Article
Capsid-binding retrovirus restriction factors: discovery, restriction specificity and implications for the development of novel therapeutics
12 Sept 2013
Abstract excerpt
The development of drugs against human immunodeficiency virus type 1 infection has been highly successful, and numerous combinational treatments are currently available. However, the risk of the emergence of resistance and the toxic effects associated with prolonged use of antiretroviral therapies have emphasized the need to consider alternative approaches. One possible area of investigation is provided by the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
